Ethos Technologies Inc. - Class A (LIFE)
LIFE moved a median of -0.31% 30 minutes after news, and +0.61% by the close. How LIFE actually reacts to news — the realized, point-in-time move the market made, measured across 83 labeled events over the last three years with zero look-ahead.
LIFE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.18% | 41% | 68 |
| 30-min | -0.31% | 32% | 68 |
| 60-min | -0.54% | 32% | 68 |
| to close | +0.61% | 56% | 68 |
| Middle 50% of LIFE reactions | -1.46% to +0.41% |
|---|---|
| Median reaction (30-min) | -0.31% |
| Measured reactions | 83 |
Half of all Ethos Technologies Inc. - Class A news events land between -1.46% and +0.41% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How LIFE reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 10 | -2.00% | 10% | -4.10% |
| Rating reiterations | 19 | +0.58% | 74% | +1.17% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how LIFE ranks against every other measured name →
That’s how LIFE usually reacts — get an email when it moves on news →Email me when LIFE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LIFE's baseline. Nothing else.
Recent LIFE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Ethos to Announce Third Quarter 2026 Financial Results on November 2, 2026 | Press release | GlobeNewswire | +4.42% | +6.68% | |
| Ethos to Present at the Goldman Sachs Communacopia + Technology Conference | Press release | GlobeNewswire | -0.23% | +2.01% | |
| Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family | Press release | GlobeNewswire | -1.32% | +2.84% | |
| Ethos Reports Second Quarter Fiscal Year 2026 Financial Results | Press release | GlobeNewswire | -3.29% | +1.17% | |
| Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children | Press release | GlobeNewswire | +0.56% | +0.37% | |
| Ethos Partners with Amanda Kloots to Help Families Take Control of the One Thing They Can | Press release | GlobeNewswire | -0.48% | +0.61% | |
| Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026 | Press release | GlobeNewswire | +0.58% | +0.57% | |
| Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential | Press release | GlobeNewswire | -2.72% | +7.36% | |
| Ethos to Present at Upcoming Investor Conferences | Press release | GlobeNewswire | +0.85% | -4.74% | |
| Ethos Announces Early Lock-Up Release | Press release | Business Wire | -2.78% | -2.30% | |
| Ethos Reports First Quarter Fiscal Year 2026 Financial Results | Press release | GlobeNewswire | +10.08% | +24.86% | |
| Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users | Press release | GlobeNewswire | +0.15% | +7.18% | |
| Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience | Press release | GlobeNewswire | -0.25% | +0.80% | |
| Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026 | Press release | GlobeNewswire | +0.38% | +1.67% | |
| Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families | Press release | GlobeNewswire | -0.30% | +5.22% | |
| Ethos to Participate in The Citizens Technology Conference | Press release | GlobeNewswire | -5.85% | +1.06% | |
| Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product | Press release | GlobeNewswire | — | — | |
| Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution | Press release | GlobeNewswire | — | — | |
| Ethos Files Registration Statement for Proposed Initial Public Offering | Press release | GlobeNewswire | — | — | |
| Ethos and Lifeforce Team Up to Help Policyholders Live Longer, Healthier Lives | Press release | GlobeNewswire | — | — | |
| Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors | Press release | GlobeNewswire | — | — | |
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K aTYR PHARMA INC For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q aTYR PHARMA INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K aTYR PHARMA INC For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form S-8 aTYR PHARMA INC | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Form 8-K aTYR PHARMA INC For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR” | Press release | GlobeNewswire | -0.55% | +1.65% | |
| Form 8-K aTYR PHARMA INC For: May 22 | SEC filing · Form 8-K | SEC EDGAR | +0.59% | +4.14% | |
| aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -1.10% | -1.65% | |
| aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference | Press release | GlobeNewswire | +0.53% | +1.32% | |
| aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis | Press release | GlobeNewswire | +2.60% | +5.20% | |
| aTyr Pharma to Present at Upcoming Investor Conferences | Press release | GlobeNewswire | +0.61% | +0.61% | |
| aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update | Press release | GlobeNewswire | +0.00% | +0.63% | |
| Form 10-Q aTYR PHARMA INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.63% | |
| Form 8-K aTYR PHARMA INC For: May 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.63% | |
| Form ARS aTYR PHARMA INC For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.06% | -2.66% | |
| Form DEF 14A aTYR PHARMA INC For: May 22 | SEC filing · Form DEF | SEC EDGAR | +1.06% | -2.66% | |
| Form DEFA14A aTYR PHARMA INC | SEC filing · Form DEFA14A | SEC EDGAR | +1.06% | -2.66% | |
| aTyr Pharma to Participate in April Investor Conferences | Press release | GlobeNewswire | -2.14% | -3.05% | |
| aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update | Press release | GlobeNewswire | +6.79% | +22.84% | |
| Form 10-K aTYR PHARMA INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +6.79% | +22.84% | |
| Form 8-K aTYR PHARMA INC For: Mar 14 | SEC filing · Form 8-K | SEC EDGAR | +6.79% | +22.84% | |
| aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results | Press release | GlobeNewswire | -1.50% | -5.00% | |
| aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants | Press release | GlobeNewswire | -1.05% | +3.14% | |
| aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity | Press release | GlobeNewswire | +0.00% | +2.53% | |
| aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor | Press release | GlobeNewswire | -4.39% | -4.05% | |
| Form EFFECT aTYR PHARMA INC | SEC filing · Form EFFECT | SEC EDGAR | +0.87% | -0.87% | |
| aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023 | Press release | GlobeNewswire | -0.91% | +1.36% | |
| aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update | Press release | GlobeNewswire | -1.72% | -3.45% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LIFE section they belong to.
Where else LIFE is measured.
LIFE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
| BASILEA PHARM AG AKT SHS (BPMUF) | 81 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Ethos Technologies Inc. - Class A's median reaction calculated?
Every labeled LIFE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 83 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 32% of LIFE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LIFE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.